Clinical Trials Directory

Trials / Unknown

UnknownNCT06287931

Probiotics for Gallstones in Post-bariatric Surgery Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Shandong Linglong Yingcheng Hospital · Network
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Obesity is an increasing epidemic worldwide and has a significant impact on human health and socioeconomics. Multiple studies have shown that bariatric surgery increases the risk of postoperative gallbladder stones. Contributing factors to gallstone formation include gallbladder motility and bile supersaturation due to rapid weight loss and cholesterol mobilization. At present, the prevention and treatment of gallbladder stones in obese patients after bariatric surgery are still controversial. In recent years, the study of ursodeoxycholic acid in preventing gallbladder stone formation after bariatric surgery has become a research hotspot. At the same time, other studies have shown that taking probiotics or digestive enzymes may improve gastrointestinal symptoms and improve quality of life after bariatric surgery. Therefore, the purpose of this study was to determine the ability of probiotics to prevent gallstone formation after bariatric surgery and to evaluate the impact of oral probiotics on quality of life in patients after bariatric surgery.

Conditions

Interventions

TypeNameDescription
DRUGUrsodoxycholic acid groupUrsodoxycholic acid, 250mg po tid x 6 months
DRUGBifidobacterium groupBifidobacteria, 210 mg po tid x 6 months

Timeline

Start date
2024-01-01
Primary completion
2025-06-01
Completion
2025-06-01
First posted
2024-03-01
Last updated
2024-03-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06287931. Inclusion in this directory is not an endorsement.